GO:0008747 N-acetylneuraminate lyase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008747 defines the enzymatic activity that reversibly cleaves N-acetylneuraminate (sialic acid) into N-acetyl-D-mannosamine and pyruvate.
• The enzyme is widely used as a biocatalyst for sialic acid production and for studying sialic acid catabolism in bacteria and humans.
• In humans, loss of N-acetylneuraminate pyruvate lyase (NPL) causes a muscle-wasting disorder characterized by elevated sialic acid and impaired energy metabolism.
• Bacterial N-acetylneuraminate lyases contribute to host colonization, biofilm formation, and virulence, as shown for Edwardsiella piscicida and Staphylococcus aureus.
• Structural and kinetic studies have revealed conserved catalytic residues and cold-adaptation features, enabling inhibitor design and industrial applications.
• CRISPR-based knockout, point-mutation, and knock-in models are essential to dissect the role of NPL in sialic acid metabolism and related diseases.
Description
N-acetylneuraminate lyase activity (GO:0008747) is a molecular function that catalyzes the reversible aldol cleavage of N-acetylneuraminate (sialic acid) to yield N-acetyl-D-mannosamine and pyruvate. This reaction is central to sialic acid catabolism and is found in diverse organisms, from bacteria to humans. The enzyme, often called N-acetylneuraminate pyruvate lyase (NPL) or sialic acid aldolase, is a member of the dihydrodipicolinate synthase (DHDPS) family and shares a conserved (beta/alpha)8-barrel fold. Researchers study this activity because it links sialic acid metabolism to bacterial virulence, host immune evasion, and human muscle physiology. In bacteria, N-acetylneuraminate lyase enables utilization of host-derived sialic acid as a carbon and nitrogen source, contributing to colonization and biofilm formation. In humans, mutations in the NPL gene cause a rare metabolic myopathy with severe muscle weakness, highlighting the importance of this activity for energy homeostasis. The enzyme also serves as a versatile biocatalyst for the industrial synthesis of sialic acid and its derivatives, which are valuable for pharmaceutical and nutraceutical applications. Given its broad biological and biotechnological relevance, GO:0008747 is a key target for structural, mechanistic, and therapeutic studies.
N-acetylneuraminate lyase activity At A Glance
| GO ID | GO:0008747 |
|---|---|
| GO term | N-acetylneuraminate lyase activity |
| Ontology | molecular_function |
| Synonym | N-acetylneuraminate aldolase activity; sialic acid aldolase activity; NPL; NALase activity |
| Major function | Reversible cleavage of N-acetylneuraminate to N-acetyl-D-mannosamine and pyruvate |
| EC number | 4.1.3.3 |
| Reaction direction | Reversible; favors cleavage in vivo |
| Cofactors | None required; uses a conserved lysine for Schiff base formation |
| Subcellular location | Cytoplasm (bacteria); cytoplasm and mitochondria (human) |
What Is GO:0008747?
GO:0008747 describes the catalysis of the reaction: N-acetylneuraminate = N-acetyl-D-mannosamine + pyruvate. In other words, it is the enzymatic activity that breaks down (or synthesizes) sialic acid by an aldol condensation mechanism, using a conserved lysine residue to form a Schiff base intermediate with pyruvate. This activity is synonymous with N-acetylneuraminate aldolase, sialic acid aldolase, and NPL (N-acetylneuraminate pyruvate lyase).
Why Is N-acetylneuraminate lyase activity Important in Cell Biology?
N-acetylneuraminate lyase activity is important because it sits at the crossroads of sialic acid metabolism, which affects bacterial pathogenesis, human energy homeostasis, and biotechnological production of sialic acid. In pathogens such as Edwardsiella piscicida and Staphylococcus aureus, the enzyme supports growth on host sialic acid and contributes to biofilm formation and virulence. In humans, loss-of-function mutations in NPL cause a muscle-wasting disease, demonstrating that this activity is essential for normal muscle function and energy metabolism. Moreover, the enzyme is a valuable biocatalyst for the industrial synthesis of sialic acid, a building block for antiviral drugs and infant formula supplements.
• Enables bacterial pathogens to catabolize host-derived sialic acid for growth and colonization.
• Contributes to biofilm formation and motility in Edwardsiella piscicida, impacting infection.
• Essential for muscle function in humans; NPL deficiency causes a metabolic myopathy.
• Provides a biocatalytic route for industrial production of sialic acid and derivatives.
• Serves as a model enzyme for studying aldolase mechanism and cold adaptation.
• Potential target for antibacterial drug design, especially against methicillin-resistant Staphylococcus aureus.
• Used in chemoenzymatic synthesis of sialidase inhibitors and sialic acid analogs.
• Involved in sialic acid catabolism in deep-sea symbiotic Mycoplasma, with biotechnological potential.
• High-throughput assays for this activity aid in screening enzyme variants and inhibitors.
• CRISPR models of NPL help dissect its role in muscle physiology and disease.
Molecular Mechanism of N-acetylneuraminate lyase activity
Substrate binding and Schiff base formation
In simple terms: The enzyme grabs the sialic acid molecule and forms a temporary chemical bond with part of it to start the reaction.
N-acetylneuraminate lyase binds its substrate, N-acetylneuraminate, in a conserved active site. A lysine residue (Lys165 in some bacterial enzymes) forms a Schiff base with the carbonyl group of the substrate, activating it for cleavage. This step is essential for catalysis and is conserved across species.
Aldol cleavage and product release
In simple terms: The enzyme then splits the sialic acid into two smaller molecules, which are released.
Following Schiff base formation, the enzyme catalyzes an aldol cleavage that breaks the C3-C4 bond of N-acetylneuraminate, yielding N-acetyl-D-mannosamine and pyruvate. The products are released from the active site, and the enzyme is ready for another cycle. The reaction is reversible, but in vivo the cleavage direction is favored.
Structural features and cold adaptation
In simple terms: The enzyme's 3D shape is like a barrel, and some versions from cold environments are more flexible to work at low temperatures.
N-acetylneuraminate lyases adopt a (beta/alpha)8-barrel fold, typical of the DHDPS family. Cold-active variants from psychrophilic organisms have increased flexibility in loops near the active site, allowing efficient catalysis at low temperatures. This structural plasticity is a target for engineering enzymes with tailored properties.
Inhibition and regulation
In simple terms: Certain molecules can block the enzyme, and its activity can be controlled by the cell's needs.
The enzyme can be inhibited by substrate analogs and transition-state mimics, which are valuable for antibacterial drug development. In bacteria, expression of the lyase is often regulated by the availability of sialic acid and global metabolic regulators. In humans, NPL activity is thought to be regulated by metabolic demand, but detailed mechanisms remain under investigation.
Kinetic properties and substrate specificity
In simple terms: The enzyme works best on sialic acid but can also act on similar molecules, and its speed can be measured.
Kinetic studies show that N-acetylneuraminate lyases have high specificity for N-acetylneuraminate, but some can also cleave related sialic acid derivatives. The enzyme from Escherichia coli has been extensively characterized, with a Km in the millimolar range and optimal pH around 7.5. High-performance liquid chromatography (HPLC) assays are commonly used to measure substrate specificity and activity.
Key Genes Involved in GO:0008747 N-acetylneuraminate lyase activity
The following genes and proteins are directly associated with N-acetylneuraminate lyase activity or its regulation across different organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NPL (human) | Encodes N-acetylneuraminate pyruvate lyase; catalyzes sialic acid cleavage | Mutations cause muscle-wasting disease; target for metabolic studies |
| nanA (E. coli) | Encodes N-acetylneuraminate lyase; sialic acid catabolism | Model enzyme for structure-function studies |
| nanA (S. aureus) | N-acetylneuraminate lyase in MRSA | Potential antibacterial target; structure solved |
| nanA (Edwardsiella piscicida) | Contributes to sialic acid utilization, biofilm, motility | Virulence factor; infection model |
| NPL (Mycoplasma) | Cold-active N-acetylneuraminate lyase from deep-sea symbiont | Biotechnological applications; cold adaptation |
| nanA (Clostridium perfringens) | Sialic acid catabolism | Role in gut colonization (inferred from other bacteria) |
| nanA (Vibrio cholerae) | Sialic acid utilization | Potential role in intestinal colonization (inferred) |
| nanA (Haemophilus influenzae) | Sialic acid catabolism | Host adaptation (inferred) |
| nanA (Streptococcus pneumoniae) | Sialic acid metabolism | Virulence and colonization (inferred) |
| nanA (Bacteroides fragilis) | Sialic acid utilization | Gut symbiosis (inferred) |
| nanA (Pseudomonas aeruginosa) | Sialic acid catabolism | Biofilm formation (inferred) |
| nanA (Klebsiella pneumoniae) | Sialic acid metabolism | Antibiotic resistance (inferred) |
| nanA (Salmonella enterica) | Sialic acid catabolism | Host colonization (inferred) |
| nanA (Yersinia pestis) | Sialic acid utilization | Virulence (inferred) |
| nanA (Listeria monocytogenes) | Sialic acid catabolism | Intracellular survival (inferred) |
| nanA (Enterococcus faecalis) | Sialic acid metabolism | Gut colonization (inferred) |
| nanA (Bifidobacterium longum) | Sialic acid utilization | Probiotic metabolism (inferred) |
| nanA (Thermotoga maritima) | Thermostable N-acetylneuraminate lyase | Industrial biocatalysis (inferred) |
How Is N-acetylneuraminate lyase activity Regulated?
The expression and activity of N-acetylneuraminate lyase are regulated at multiple levels. In bacteria, the gene is often part of an operon induced by sialic acid availability and subject to catabolite repression. In Edwardsiella piscicida, the lyase contributes to biofilm formation and motility, suggesting regulation by quorum sensing and global virulence regulators. In humans, NPL is constitutively expressed but its activity may be modulated by metabolic demand and substrate availability; however, specific regulatory mechanisms remain poorly defined. Structural studies indicate that the enzyme's activity can be inhibited by substrate analogs, providing a means for pharmacological regulation.
N-acetylneuraminate lyase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPL (human) | NPL deficiency myopathy | Knockout mouse or patient-derived iPSCs |
| nanA (Edwardsiella piscicida) | Bacterial infection and biofilm | Knockout in E. piscicida; infection model |
| nanA (Staphylococcus aureus) | MRSA virulence | Knockout in S. aureus; inhibitor testing |
| NPL (human) | Sialic acid metabolism disorders | Point-mutation knock-in in cell lines |
| nanA (E. coli) | Model for enzyme mechanism | Overexpression and purification |
NPL deficiency and muscle-wasting disease
Biallelic loss-of-function mutations in the human NPL gene cause a rare autosomal recessive disorder characterized by severe muscle weakness, atrophy, and elevated levels of sialic acid in urine and plasma. The disease, sometimes called NPL deficiency or sialic aciduria, highlights the essential role of N-acetylneuraminate lyase activity in muscle energy metabolism. Patients present with early-onset muscle weakness and failure to thrive, and the condition can be life-threatening.
Bacterial pathogenesis and biofilm formation
In bacterial pathogens such as Edwardsiella piscicida, N-acetylneuraminate lyase enhances infection, biofilm formation, and motility. The enzyme allows bacteria to utilize host-derived sialic acid as a carbon source, promoting colonization and immune evasion. In Staphylococcus aureus, the lyase is a potential target for antibacterial drugs, especially against methicillin-resistant strains.
Sialic acid metabolism and cancer
Altered sialic acid metabolism is a hallmark of cancer, and enzymes involved in sialic acid catabolism, including N-acetylneuraminate lyase, may influence tumor progression. However, direct evidence linking NPL to cancer remains limited, and further studies are needed to establish its role.
From N-acetylneuraminate lyase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NPL loss affect muscle function? | NPL knockout mouse or human iPSC-derived myotubes |
| How does NPL mutation affect enzyme activity? | Point-mutation knock-in in HEK293 cells |
| Can NPL be targeted for antibacterial therapy? | Bacterial knockout and inhibitor screening |
| What is the role of NPL in sialic acid catabolism? | Overexpression of NPL in E. coli |
| How does cold adaptation affect NPL activity? | Knock-in of cold-active NPL variants in mesophilic bacteria |
| Does NPL contribute to biofilm formation? | Knockout in Edwardsiella piscicida; biofilm assay |
How to Study the N-acetylneuraminate lyase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HPLC | Substrate and product concentrations | Enzyme kinetics and substrate specificity |
| Coupled enzyme assay | Pyruvate release | High-throughput screening of inhibitors |
| X-ray crystallography | 3D structure of enzyme | Active site mapping and inhibitor design |
| CRISPR knockout | Loss of gene function | Phenotypic analysis in cells and animals |
| Site-directed mutagenesis | Effect of point mutations | Structure-function studies |
| Metabolomics (LC-MS) | Sialic acid and metabolites | Disease biomarker discovery |
| Biofilm assay | Biofilm formation | Bacterial virulence studies |
| qRT-PCR | Gene expression levels | Regulation studies |
Enzymatic activity assays
N-acetylneuraminate lyase activity is typically measured using a coupled assay that detects pyruvate formation (e.g., lactate dehydrogenase) or by HPLC to separate substrate and products. These methods allow determination of kinetic parameters and substrate specificity.
Structural biology
X-ray crystallography and cryo-EM have been used to solve structures of N-acetylneuraminate lyases from various organisms, revealing the conserved (beta/alpha)8-barrel fold and active-site residues. These studies guide inhibitor design and protein engineering.
Genetic manipulation and CRISPR
CRISPR-Cas9 knockout, point mutation, and knock-in models are powerful tools to study the physiological role of NPL. For example, NPL knockout mice recapitulate muscle-wasting phenotypes, and point mutations can mimic human disease variants.
Metabolomics and flux analysis
Mass spectrometry-based metabolomics can quantify sialic acid and its metabolites in cells and tissues, providing insights into the metabolic consequences of altered NPL activity.
How CRISPR Can Be Used to Study GO:0008747 N-acetylneuraminate lyase activity
Knockout
CRISPR-Cas9 knockout of NPL or bacterial nanA eliminates N-acetylneuraminate lyase activity, allowing researchers to study its role in sialic acid catabolism, muscle function, and bacterial virulence. Knockout models often display metabolic accumulation of sialic acid and impaired growth on sialic acid as a sole carbon source.
Point Mutation
Point mutations can be introduced into the NPL gene to mimic human disease variants or to probe catalytic residues. For example, mutation of the conserved lysine abolishes enzyme activity, confirming its essential role in catalysis. Such models help correlate genotype with enzymatic and phenotypic outcomes.
Knock-in
Knock-in of tagged NPL (e.g., FLAG or GFP) enables localization and interaction studies. Knock-in of disease-associated mutations into cell lines or mice provides valuable models for studying NPL deficiency myopathy.
Overexpression
Overexpression of NPL in bacterial or mammalian cells is used to produce recombinant enzyme for structural and kinetic studies, as well as to investigate the effects of increased sialic acid catabolism on cellular metabolism.
How EDITGENE Supports N-acetylneuraminate lyase activity Research
Researchers studying N-acetylneuraminate lyase activity-related genes often need to determine whether a candidate gene is causally involved in sialic acid metabolism, muscle function, or bacterial virulence. EDITGENE provides comprehensive CRISPR-based services to create precisely engineered cell and animal models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for N-acetylneuraminate lyase activity research.
Frequently Asked Questions About N-acetylneuraminate lyase activity
What is N-acetylneuraminate lyase activity?
It is the enzymatic activity (GO:0008747) that catalyzes the reversible cleavage of N-acetylneuraminate (sialic acid) into N-acetyl-D-mannosamine and pyruvate.
What genes are involved in N-acetylneuraminate lyase activity?
The main gene in humans is NPL; in bacteria, nanA encodes the enzyme. Other organisms have orthologs with similar functions.
What diseases are associated with NPL mutations?
Biallelic mutations in NPL cause a rare muscle-wasting disease with sialic aciduria, characterized by severe muscle weakness.
How is N-acetylneuraminate lyase activity measured?
Common methods include HPLC and coupled enzyme assays that detect pyruvate formation.
What is the role of N-acetylneuraminate lyase in bacteria?
It allows bacteria to utilize host-derived sialic acid, contributing to colonization, biofilm formation, and virulence.
Can N-acetylneuraminate lyase be used industrially?
Yes, it is used as a biocatalyst for the synthesis of sialic acid and its derivatives.
What is the structure of N-acetylneuraminate lyase?
It adopts a (beta/alpha)8-barrel fold and uses a conserved lysine for Schiff base formation.
How can CRISPR help study N-acetylneuraminate lyase?
CRISPR knockout, point mutation, and knock-in models enable precise functional studies of NPL in cells and animals.
Is N-acetylneuraminate lyase activity reversible?
Yes, the reaction is reversible, but in vivo the cleavage direction is favored.
What are synonyms for N-acetylneuraminate lyase activity?
Common synonyms include N-acetylneuraminate aldolase, sialic acid aldolase, NPL, and NALase.
Conclusion
N-acetylneuraminate lyase activity (GO:0008747) is a fundamental enzymatic function that bridges sialic acid metabolism with bacterial pathogenesis and human muscle physiology. Its study offers insights into metabolic diseases, host-pathogen interactions, and biotechnological applications. With advanced CRISPR tools from EDITGENE, researchers can precisely manipulate NPL and related genes to uncover new therapeutic targets and mechanisms.
References
- 1. Cheng C et al.. 2022. Recombinant human N-acetylneuraminate lyase as a tool to study clinically relevant mutant variants.. Carbohydr Res 516:108561 PMID: 35487178
- 2. Vo LK et al.. 2022. Enhancement of Edwardsiella piscicida infection, biofilm formation, and motility caused by N-acetylneuraminate lyase.. Glycoconj J 39(3):429-442 PMID: 35192095
- 3. North RA et al.. 2016. Structure and inhibition of N-acetylneuraminate lyase from methicillin-resistant Staphylococcus aureus.. FEBS Lett 590(23):4414-4428 PMID: 27943302
- 4. Wang SL et al.. 2018. Molecular Characterization of a Novel N-Acetylneuraminate Lyase from a Deep-Sea Symbiotic Mycoplasma.. Mar Drugs 16(3) PMID: 29510563
- 5. Wen XY et al.. 2018. Sialic acid catabolism by N-acetylneuraminate pyruvate lyase is essential for muscle function.. JCI Insight 3(24) PMID: 30568043
- 6. Shukla AK et al.. 1986. Analysis of sialidase and N-acetylneuraminate pyruvate-lyase substrate specificity by high-performance liquid chromatography.. Anal Biochem 158(1):158-64 PMID: 2879483
- 7. Uchida Y et al.. 1984. Purification and properties of N-acetylneuraminate lyase from Escherichia coli.. J Biochem 96(2):507-22 PMID: 6389524
- 8. Gurung MK et al.. 2019. Features and structure of a cold active N-acetylneuraminate lyase.. PLoS One 14(6):e0217713 PMID: 31185017
